|
|
Volumn 21, Issue 10 Suppl 1, 2011, Pages
|
|
Efficacy of trabectedin in platinum-sensitive-relapsed ovarian cancer: new data from the randomized OVA-301 study.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1,3 DIOXOLANE DERIVATIVE;
ALKYLATING AGENT;
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIBIOTIC;
DOXORUBICIN;
PLATINUM DERIVATIVE;
TETRAHYDROISOQUINOLINE DERIVATIVE;
TRABECTEDIN;
FEMALE;
HUMAN;
MULTICENTER STUDY (TOPIC);
OVARY TUMOR;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RECURRENT DISEASE;
REVIEW;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS, ALKYLATING;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DIOXOLES;
DOXORUBICIN;
FEMALE;
HUMANS;
MULTICENTER STUDIES AS TOPIC;
OVARIAN NEOPLASMS;
PLATINUM COMPOUNDS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RECURRENCE;
TETRAHYDROISOQUINOLINES;
|
|
EID: 79960073564
PISSN: None
EISSN: 15251438
Source Type: Journal
DOI: 10.1097/igc.0b013e318217b321 Document Type: Review |
|
Times cited : (21)
|
|
References (0)
|
